Ticagrelor
Ticagrelor is a prescription medication that helps prevent blood clots by reducing platelet aggregation. It's available as 60 mg and 90 mg oral tablets, used to lower the risk of heart attack or stroke in patients with certain heart conditions. This generic version is manufactured by AvKARE under application ANDA208596. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ticagrelor is a prescription medication that helps prevent blood clots by reducing platelet aggregation. It's available as 60 mg and 90 mg oral tablets, used to lower the risk of heart attack or stroke in patients with certain heart conditions. This generic version is manufactured by AvKARE under application ANDA208596. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ticagrelor",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ticagrelor — ANDA 218962 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218962"
}
]
|
| identifier | ANDA218962 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ticagrelor |
